Study results show that treatment with Seretide/Advair (salmeterol/fluticasone propionate ) slows the progression of Chronic Obstructive Pulmonary Disease (COPD) by lowering a patient’s rate of lung function decline compared with those receiving placebo.
Filed under: gpcr | Tagged: Advair, agonist, Beta 2 adrenoceptor, fluticasone, GKS, salmeterol
